Table 1.

Summary of active clinical parameters

	Clinical status
Treatment	Incidence of EAE (%)	Days of onset	Mean of maximal score
Vehicle	100 (27/27)	13.2 ± 0.6	2.9 ± 0.2
rTl-gal	100 (20/20)	13.5 ± 0.8	3.3 ± 0.1*

Experimental autoimmune encephalomyelitis (EAE) clinical parameters were observed in myelin oligodendrocyte glycoprotein (MOG)-induced EAE in recombinant Toxascaris leonine galectin (rTl-gal)-treated and vehicle-treated mice. Each number represents the mean ± standard error of the mean of six independent experiments. Statistical difference of P < 0·05 (^*) for rTl-gal-treated mice versus vehicle controls is indicated.